Clinical Trials Logo
NCT number NCT03356392
Study type Observational [Patient Registry]
Source Universitätsklinikum Hamburg-Eppendorf
Contact Anna Christina Alegiani, Dr
Phone 0049-15222816679
Email a.alegiani@uke.de
Status Recruiting
Phase N/A
Start date June 2015
Completion date June 2025

Clinical Trial Summary

The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03366818 - New Stent Retriever, VERSI System for AIS N/A
Not yet recruiting NCT03287076 - A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke Phase 2
Recruiting NCT02223273 - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke ( BRIDGE-Stroke) Phase 4
Recruiting NCT02586233 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Phase 1/Phase 2
Suspended NCT01694381 - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor N/A
Not yet recruiting NCT01594190 - Physical Activity Immediately After Acute Cerebral Ischemia N/A
Completed NCT01120301 - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Phase 3
Completed NCT01021319 - Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI) N/A
Completed NCT00963989 - Imaging Guided Patient Selection for Interventional Revascularization Therapy Phase 4
Recruiting NCT00710164 - Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke Phase 2/Phase 3
Completed NCT00777140 - Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Phase 2
Recruiting NCT02964702 - Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan) N/A
Recruiting NCT02133521 - DLBS1033 for Acute Ischemic Stroke Patients Phase 2/Phase 3
Terminated NCT02362984 - DLBS1033 for the Treatment of Acute Ischemic Stroke Phase 3
Completed NCT02297984 - Serum Neuroglobin and HIF-1α in Acute Ischemic Stroke N/A
Completed NCT02415972 - Dynamic Contrast-enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Acute Ischemic Stroke N/A
Recruiting NCT00874601 - Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke Phase 4
Recruiting NCT00574262 - Quality Assessment in Acute Stroke Care N/A
Completed NCT00756249 - Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke Phase 1
Completed NCT00203710 - Concentric Retriever Device (CRD) in Acute Ischemic Stroke N/A